Internal Medicine, Hematology · Little Rock, AR
NPI
1831289313
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
4301 W Markham St # 783
Little Rock, AR, 72205
Phone (501) 686-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
461 services
Medicare patients, 2024
174
Average age 71
Drug cost, 2024
$1.2M
477 prescriptions
Company payments, 2025
$3,000
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rangaswamy Govindarajan was code 99215 (office e&m - established), 173 times for 72 patients. In total Rangaswamy Govindarajan billed 461 services in 9 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 173 | 72 | $101.03 | $17K |
| 99214 Office E&M - Established | Facility | 107 | 64 | $67.53 | $7,226 |
| 99213 Office E&M - Established | Facility | 80 | 62 | $42.48 | $3,398 |
| 99205 Office E&M - New | Facility | 46 | 46 | $125.74 | $5,784 |
| 99231 Hospital E&M - Subsequent | Facility | 32 | 22 | $34.79 | $1,113 |
| 99221 Hospital E&M - Initial | Facility | 15 | 15 | $59.49 | $892 |
By year: 2022 $38K for 573 services; 2023 $41K for 497 services; 2024 $37K for 461 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rangaswamy Govindarajan prescribed most often to Medicare patients was Ondansetron Odt (Ondansetron), with 53 prescriptions and refills. In total Rangaswamy Govindarajan wrote 477 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Odt Ondansetron | 53 | 54 | 24 | $865 |
| Potassium Chloride Generic | 46 | 56 | 13 | $493 |
| Imatinib Mesylate Generic | 38 | 38 | Under 11 | $76K |
| Creon Lipase/Protease/Amylase | 29 | 41 | Under 11 | $30K |
| Prochlorperazine Maleate Generic | 28 | 28 | 21 | $715 |
| Gabapentin Generic | 27 | 27 | Under 11 | $225 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 22 | 22 | Under 11 | $303 |
| Eliquis Apixaban | 21 | 27 | Under 11 | $15K |
| Pantoprazole Sodium Generic | 14 | 20 | Under 11 | $179 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 14 | 14 | Under 11 | $168 |
| Stivarga Regorafenib | 13 | 13 | Under 11 | $303K |
Brand drugs: 103 claims; generic drugs: 374 claims; opioid claims: 50.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rangaswamy Govindarajan $3,000 ($3,000 in general payments such as food, travel and fees) from 1 company. The largest payer was SpringWorks Therapeutics, Inc. with $3,000.
| Company | Payments | Amount |
|---|---|---|
| SpringWorks Therapeutics, Inc. | 1 | $3,000 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.